NEI Payline 2026: No Cutoff and a 12.8% New R01 Rate

Every institute's numbers sit side by side in the NIH and NSF funding odds tracker.

NEI's honest answer to "what's the payline" is short: there isn't one. The more useful question is what happened to NEI's new R01 pool in FY2025, because the success rate there nearly halved in a single year.

NEI Payline Status: 0 Published Cutoffs in FY2026

NEI publishes 0 percentile or impact-score cutoffs for FY2026. Its FY2026 funding policy page (opens in a new tab) says the institute "does not use a fixed 'payline' or strict score cutoff" and makes all funding decisions under the NIH Unified Funding Strategy. Final decisions weigh scientific merit, program relevance, portfolio balance, alignment with NEI priorities and available funds.

The mechanics are spelled out in one sentence: "Each council round, NEI ranks applications within programmatic areas based on program recommendations and develops a funding plan designed to support the greatest number of meritorious projects possible." Program recommendations draw on peer review, the NEI Strategic Plan, NIH and HHS priorities, and advice from the National Advisory Eye Council.

That puts NEI squarely inside the NIH-wide change. NIH's funding decisions page (opens in a new tab) says institutes "will no longer employ these cutoff points in overall impact scores to determine which applications to fund." NEI also says it gives special consideration to new and early-stage investigators and to applications that fill gaps in its research portfolio, and it strongly encourages applicants to talk with program staff before writing.

The page header also notes that NIH is operating under a continuing resolution (NOT-OD-26-131), so FY2027 decisions may follow different budget rules than the ones above.

NEI R01 Success Rates, FY2019 to FY2025

From FY2019 to FY2024, NEI funded between 20.9% and 26.0% of new R01 applications every year. FY2025 broke that pattern. All figures below come from NIH's success-rate tables (opens in a new tab), table 206.

For example, NEI received 765 new R01 applications in FY2025, its highest count in this seven-year run, and funded 98 of them. A year earlier it funded 164 of 694. Applications rose by 71 while awards fell by 66, and both moves pushed the rate down.

According to NIH Data Book table 217, NEI's success rate for all research project grants fell from 26.7% (329 of 1,233) in FY2024 to 17.6% (240 of 1,362) in FY2025.

Put next to the NIH-wide picture, NEI was still slightly better than average. NIH funded 9.9% of new R01 applications across all institutes in FY2025 (3,405 of 34,491), so NEI's 12.8% sits about three points higher. Before FY2025, though, NEI ran well above the NIH average: 23.6% against 14.9% NIH-wide in FY2024. The institute lost most of its edge in one year.

Three cautions apply when reading the table:

• Success rates aren't paylines. A rate divides awards by applications reviewed. It includes unscored applications, so the share of discussed applications that NEI funded was higher than 12.8%.
• Resubmissions are counted once. If an A0 and its A1 both arrive in the same fiscal year, NIH counts one application.
• The R01 and R37 column mixes types. It adds new, renewal and revision rows together, so it moves less than the new-application rate.

New Versus Renewal: A 19.8-Point Gap in FY2025

The renewal line is the part of NEI's data that most applicants underestimate. According to NIH Data Book table 206, NEI funded 62 of 190 competing R01 renewals in FY2025 (32.6%), against 12.8% for new applications. That's a gap of 19.8 percentage points.

Renewal rates have drifted down too: from 49.7% in FY2020 to 38.3% in FY2024 and 32.6% in FY2025. But they never fell below 30%, while the new-application rate dropped by almost half in one year.

What this means in practice:

• If you hold an NEI R01 that's coming up for renewal, the odds are still roughly one in three. Plan the renewal on time rather than letting the grant lapse and reapplying as new.
• If you're applying for your first NEI R01, the FY2025 figure, about one in eight, is the honest baseline until FY2026 rates appear.
• A new application that scores well but sits in a crowded programmatic area can lose to a weaker score elsewhere, because NEI ranks within areas.

Grantsights checked NEI's FY2026 policy text against the Data Book to see if it names a renewal preference. It doesn't. The gap shows up in outcomes, not in a stated rule, so don't treat it as guaranteed.

FY2026 Award Records and Forward Funding at NEI

RePORTER records 125 new NEI R01 and R37 awards in FY2026, up from 99 in FY2025. Grantsights analysis of NIH RePORTER award records, pulled November 8, 2026, also counted how many NEI awards were paid several years at once (budget periods longer than about 13 months):

NEI had 12 multi-year funded new R01s in FY2025, against 1 in FY2024. Each of those used several years of money in one fiscal year. NIH's FY2025 by-the-numbers post (opens in a new tab) said NIH-wide changes "were likely due in part to more awards being forward funded than previous years." NIH's FY2026 fiscal policy notice (opens in a new tab) sets the rules for the current year.

The Data Book money lines fit that picture. NEI's R01 and R37 funding went from $125.1 million in FY2024 to $112.2 million in FY2025, but the average per award jumped from $536,930 to $701,186.

Here's the red flag in reading these counts: 125 FY2026 awards is not a success rate. RePORTER shows what NEI funded, not how many applications it reviewed. If NEI's FY2026 application count stayed near FY2025's 765, the rate would rise; if applications kept climbing, it might not. NIH hasn't published FY2026 Data Book rates yet, and Grantsights doesn't estimate them.

Budget Size and Project Length at NEI

The median first-year direct cost on new single-year NEI R01s reached $410,042 in FY2026, up from $327,207 in FY2024. Grantsights read every new NEI R01 and R37 award paid one year at a time:

Unlike some institutes, NEI's FY2026 page doesn't set a $500,000 priority line or an average-duration target. The record still shows that most new NEI R01s come in under $500,000 in direct costs, so a large budget needs a clear justification. The modular budget guide covers how to build one.

Project periods shifted, too. In FY2024, 95 of 166 new awards ran five years and 60 ran four. In FY2026, 68 of 125 ran four years and 49 ran five. NEI's page doesn't explain the shift, so Grantsights reports it without a cause: write aims that still make sense if the award is four years rather than five.

When NEI Awards Go Out

In FY2026, 39 of 125 new NEI R01 notices went out in September, the final month of the fiscal year, with 31 in August and 26 in April. FY2025 was spread more evenly, with no month above 14. A silent stretch after council isn't a rejection. It's also not a reason to hold off on a resubmission if your summary statement points to fixable problems; the resubmission guide walks through the A1.

Where NEI's new R01s went also moved. In FY2024, Johns Hopkins University led with 14 new awards; in FY2026 UCLA, the University of Washington and Johns Hopkins each had 5. California led states in all three years (23, 17 and 17 awards).

NEI R21, R56 and Career Awards Since FY2023

NEI's R21 rate fell from 24.6% in FY2024 to 17.6% in FY2025, according to NIH Data Book table 206 (58 of 330 applications). That's barely above the 16.8% rate for all NEI R01 and R37 applications, so the R21 isn't a back door. The R21 success rate page compares NEI with other institutes, and the R21 award history lists recent winners.

NEI made 1 R56 award in FY2023, 2 in FY2024 and 5 in FY2025. The NIH success rate definition (opens in a new tab) counts an unfunded R01 later funded as an R56 as a funded application, but at NEI that affects only a handful of cases.

Training and career mechanisms held up better than new R01s. From NIH tables 203 and 204:

The K pools are tiny, so one award changes the rate by 10 points or more. The K99 line, with 46 applications, is the steadiest: about three in ten in both years. For comparisons across institutes, see the K award success rates by institute and the F31 success rate by institute.

What NEI's Policy Page Doesn't Tell You

NEI's policy page is short, and it leaves 4 practical questions open:

A common mistake is treating an old NEI percentile rumor as a payline. Any number passed around a department reflects a past year, a past budget and the old cutoff system. Under ranking within programmatic areas, two applications with the same percentile in different areas can get different outcomes. The program officer is the only person who can tell you where your score sits in this council round. The summary statement guide helps you prepare for that call.

The page also doesn't say how much the early-stage preference is worth. NEI calls itself strongly committed to new and early-stage investigators, but it publishes no separate ESI percentile, no ESI award target, and no ESI success rate. The Data Book rows used on this page don't split NEI applicants by career stage either. So an ESI applicant should treat the preference as a tiebreaker near the funding line, not as a fixed bonus, and ask program staff how it played out in the last council round.

An application also fails because of fit, not only score. NEI's page lists alignment with its Strategic Plan as part of program recommendations, so a strong score on a project NEI sees as peripheral is still at risk.

Submit, Renew, or Wait: Decision Table

For the NIH-wide view, see the NIH R01 success rate data and the score explainer. The sibling NIBIB payline page covers an institute that does publish budget cuts. Foundation and federal vision research funding beyond NIH is searchable in Grantsights grant search.

Sources

• NEI FY2026 funding policies and considerations (opens in a new tab)
• NIH funding decisions and the Unified Funding Strategy (opens in a new tab)
• NIH Data Book success-rate tables (opens in a new tab) (tables 203, 204, 206 and 217)
• NIH success rate definition (opens in a new tab)
• NIH, Fiscal Year 2025 By the Numbers (opens in a new tab)
• NOT-OD-26-059, Notice of Fiscal Policies in Effect for FY 2026 (opens in a new tab)
• NIH RePORTER (opens in a new tab) and the RePORTER API (opens in a new tab)

Related Guides

• NIH paylines explained
• NIH R01 success rate data
• NIDDK payline
• NIH K award success rates by institute
• How to resubmit an NIH grant